The matri-cellular proteins 'cysteine-rich, angiogenic-inducer, 61' and 'connective tissue growth factor' are regulated in experimentally-induced sepsis with multiple organ dysfunction

Innate Immunity

Volumn 18, Issue 5, 2012, Pages 717-726

  Hviid, Claus V B ^a   Erdem, Johanna Samulin ^a   Kunke, David ^a   Ahmed, Shakil M ^a   Kjeldsen, Signe F ^a   Wang, Yun Yong ^a   Attramadal, Håvard ^a   Aasen, Ansgar O ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

61, multiple organ failure; angiogenic inducer; Connective tissue growth factor; cysteine rich; nephroblastoma overexpressed gene; sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CONNECTIVE TISSUE GROWTH FACTOR; CXCL1 CHEMOKINE; CYSTEINE RICH PROTEIN 61; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDITIS; CECUM; CONTROLLED STUDY; EXPERIMENTAL LIGATION; GENE EXPRESSION; HEART; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY; LIVER; LIVER CELL; LUNG; MALE; MEDIATOR RELEASE; MULTIPLE ORGAN FAILURE; NONHUMAN; PROTEIN EXPRESSION; PUNCTURE; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SPLEEN; WESTERN BLOTTING;

ANIMALS; CECUM; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE-RICH PROTEIN 61; GENE EXPRESSION REGULATION; HUMANS; LIGATION; LIVER; LUNG; MALE; MODELS, ANIMAL; MULTIPLE ORGAN FAILURE; PUNCTURES; RATS; RATS, WISTAR; SEPSIS;

RATTUS;

EID: 84867034067     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425912436764     Document Type: Article

References (46)

1. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992 ; 101: 1644-1655
2. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003 ; 348: 1546-1554
3. Balestra GM, Legrand M, Ince C. Microcirculation and mitochondria in sepsis: getting out of breath. Curr Opin Anaesthesiol. 2009 ; 22: 184-190
4. Harrois A, Huet O, Duranteau J. Alterations of mitochondrial function in sepsis and critical illness. Curr Opin Anaesthesiol. 2009 ; 22: 143-149
5. Ince C. The microcirculation is the motor of sepsis. Crit Care. 2005 ; 9: 13-19
6. Peters K, Unger RE, Brunner J, et al. Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res. 2003 ; 60: 49-57
7. Brown KA, Brain SD, Pearson JD, et al. Neutrophils in development of multiple organ failure in sepsis. Lancet. 2006 ; 368: 157-169
8. Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol. 2009 ; 41: 771-783
9. Kular L, Pakradouni J, Kitabgi P, et al. The CCN family: A new class of inflammation modulators?. Biochimie. 2011 ; 93: 377-388
10. Babic AM, Chen CC, Lau LF. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol. 1999 ; 19: 2958-2966
11. Babic AM, Kireeva ML, Kolesnikova TV, et al. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA. 1998 ; 95: 6355-6360
12. Delmolino LM, Stearns NA, Castellot JJ. COP-1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells. J Cell Physiol. 2001 ; 188: 45-55
13. Lee HY, Chung JW, Youn SW, et al. Forkhead transcription factor FOXO3a is a negative regulator of angiogenic immediate early gene CYR61, leading to inhibition of vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res. 2007 ; 100: 372-380
14. Leu SJ, Lam SC, Lau LF. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem. 2002 ; 277: 46248-46255
15. Lin CG, Leu SJ, Chen N, et al. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem. 2003 ; 278: 24200-24208
16. Shimoyama T, Hiraoka S, Takemoto M, et al. CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration. Arterioscler Thromb Vasc Biol. 2010 ; 30: 675-682
17. Jedsadayanmata A, Chen CC, Kireeva ML, et al. Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J Biol Chem. 1999 ; 274: 24321-24327
18. Schober JM, Chen N, Grzeszkiewicz TM, et al. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood. 2002 ; 99: 4457-4465
19. Bai T, Chen CC, Lau LF. Matricellular protein CCN1 activates a proinflammatory genetic program in murine macrophages. J Immunol. 2010 ; 184: 3223-3232
20. Cicha I, Yilmaz A, Klein M, et al. Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler Thromb Vasc Biol. 2005 ; 25: 1008-1013
21. Artigas A, Bernard GR, Carlet J, et al. The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med. 1998 ; 157: 1332-1347
22. Chen CC, Young JL, Monzon RI, et al. Cytotoxicity of TNFalpha is regulated by integrin-mediated matrix signaling. EMBO J. 2007 ; 26: 1257-1267
23. Cohen J. The immunopathogenesis of sepsis. Nature. 2002 ; 420: 885-891
24. Matsuda N, Hattori Y. Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J Smooth Muscle Res. 2007 ; 43: 117-137
25. Miller DS, Sen M. Potential role of WISP3 (CCN6) in regulating the accumulation of reactive oxygen species. Biochem Biophys Res Commun. 2007 ; 355: 156-161
26. Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med. 2007 ; 35: 2408-2416
27. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003 ; 348: 138-150
28. Miyaji T, Hu X, Yuen PS, et al. Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int. 2003 ; 64: 1620-1631
29. Wang YY, Ryg U, Dahle MK, et al. Liver X receptor protects against liver injury in sepsis caused by rodent cecal ligation and puncture. Surg Infect (Larchmt). 2011 ; 12: 283-289
30. Ahmed MS, Oie E, Vinge LE, et al. Connective tissue growth factor-a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. J Mol Cell Cardiol. 2004 ; 36: 393-404
31. Maeder M, Fehr T, Rickli H, et al. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest. 2006 ; 129: 1349-1366
32. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, et al. Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation. Am J Pathol. 2001 ; 159: 1199-1209
33. Cavaillon JM, Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res. 2006 ; 12: 151-170
34. Carlsen H, Moskaug JO, Fromm SH, et al. In vivo imaging of NF-kappa B activity. J Immunol. 2002 ; 168: 1441-1446
35. Yao L, Berman JW, Factor SM, et al. Correlation of histopathologic and bacteriologic changes with cytokine expression in an experimental murine model of bacteremic Staphylococcus aureus infection. Infect Immun. 1997 ; 65: 3889-3895
36. Panutsopulos D, Arvanitis DL, Tsatsanis C, et al. Expression of heregulin in human coronary atherosclerotic lesions. J Vasc Res. 2005 ; 42: 463-474
37. Leask A, Abraham DJ. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci. 2006 ; 119: 4803-4810
38. Moritani NH, Kubota S, Sugahara T, et al. Comparable response of ccn1 with ccn2 genes upon arthritis: An in vitro evaluation with a human chondrocytic cell line stimulated by a set of cytokines. Cell Commun Signal. 2005 ; 3: 6-6
39. Abraham DJ, Shiwen X, Black CM, et al. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem. 2000 ; 275: 15220-15225
40. Cooker LA, Peterson D, Rambow J, et al. TNF-alpha, but not IFN-gamma, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis. Am J Physiol Renal Physiol. 2007 ; 293: 157-165
41. Jin Y, Kim HP, Ifedigbo E, et al. Cyr61 protects against hyperoxia-induced cell death via Akt pathway in pulmonary epithelial cells. Am J Respir Cell Mol Biol. 2005 ; 33: 297-302
42. Rother M, Krohn S, Kania G, et al. Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator. Circulation. 2010 ; 122: 2688-2698
43. Ahmed MS, Gravning J, Martinov VN, et al. Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol. 2011 ; 300: 1291-1302
44. Mutunga M, Fulton B, Bullock R, et al. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med. 2001 ; 163: 195-200
45. Chen S, Rong M, Platteau A, et al. CTGF disrupts alveolarization and induces pulmonary hypertension in neonatal mice: implication in the pathogenesis of severe bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2011 ; 300: 330-340
46. Sanchez-Lopez E, Rayego S, Rodrigues-Diez R, et al. CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. J Am Soc Nephrol. 2009 ; 20: 1513-1526